Biohaven (NYSE: BHVN) net income
Biohaven reported a net loss of $738.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $846.4m. Earnings per share were −$6.86.
Biohaven's best year of the last 5 was fiscal 2021. It reported a loss in 5 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$738.8m | — | — | −$6.86 |
| 2024 | −$846.4m | — | — | −$9.28 |
| 2023 | −$408.2m | — | — | −$5.73 |
| 2022 | −$570.3m | — | — | −$12.75 |
| 2021 | −$213.8m | — | — | −$5.43 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Biohaven net income compared with its sector
By net income for its latest fiscal year, Biohaven ranks 486th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 484th | Sarepta Therapeutics | −$713.4m | −32.5% |
| 485th | BridgeBio Pharma | −$732.9m | −146.0% |
| 486th | Biohaven | −$738.8m | — |
| 487th | Vaxcyte | −$766.6m | — |
| 488th | Cytokinetics | −$785.0m | −891.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Biohaven
- How much did Biohaven earn in fiscal 2025?
- Biohaven reported a net loss of $738.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $846.4m.
- What are the earnings per share of Biohaven?
- They were −$6.86 in fiscal 2025, compared with −$9.28 in fiscal 2024.
- Where does Biohaven rank in its sector by net income?
- It ranks 486th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Biohaven come from?
- From the annual report (Form 10-K) that Biohaven files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Biohaven files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Biohaven: the Biohaven page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.